This application relates in general to electrocardiography and physiology monitoring and, in particular, to a wearable electrocardiography and physiology monitoring ensemble.
An electrocardiogram (ECG) measures and records electrical potential signals and visually depicts heart electrical activity over time. Conventionally, a standard 12-lead configuration is used in-clinic to record cardiac electrical signals from established chest locations. Physicians use ECGs to diagnose heart problems and other health concerns during appointments; however, spot ECG recording may not always detect sporadic conditions, including conditions affected by fluctuations in blood pressure, blood sugar, respiratory function, temperature, cardiac physiology and pathophysiology, or cardiac rhythm.
Physicians may provide improved diagnoses through ambulatory ECG monitoring that increases the odds of capturing sporadic conditions, during which a subject can also engage in activities of daily living. While long-term extended ambulatory monitoring in-clinic is implausible and impracticable, diagnostic efficacy can be improved through long-term extended ambulatory ECG monitoring. A 30-day observation period is considered the “gold standard,” but has heretofore proven unworkable because existing ECG monitoring systems have been arduous to employ, cumbersome to the patient, and expensive.
Extended ECG monitoring is further complicated by patient intolerance to long-term electrode wear and predisposition to skin irritation. Moreover, natural materials from the patient's body, such as hair, sweat, skin oils, and dead skin cells, can get between an electrode, adhesives, and the skin's surface, which can adversely affect electrode contact and cardiac signal recording quality. Patient physical movement and clothing can impart forces on the ECG electrode contact point; inflexibly fastened ECG electrodes are particularly prone to becoming dislodged. Precisely re-placing a dislodged ECG electrode may be essential to ensuring signal capture at the same fidelity. Dislodgment may occur unbeknownst to the patient, rendering the ECG recordings worthless.
The high cost of the patient-wearable components used to provide long-term extended ECG monitoring can also negatively influence the availability and use of monitors. Disposable components, such as adhesive electrodes, ideally should be inexpensive, while more complex components, particularly the electronic hardware that detects and records ECG and related physiological data, may be unavoidably expensive. Costs can be balanced by designing the electric hardware to be re-usable, but when the total cost of a full ECG monitoring ensemble remains high, despite the utilization of re-usable parts, the number of monitors available for use by healthcare providers can be inhibited. Cost, then, becomes a barrier to entry, which, in turn, can hinder or prevent healthcare providers from obtaining the means with which to efficaciously identify the physiology underlying sporadic cardiac arrhythmic conditions and can ultimately contribute to a failure to make proper and timely medical diagnose.
ECG data are crucial for diagnosing many cardiovascular conditions. For example, detecting abnormal respiratory function with ECG data showing normal respiratory variation may facilitate diagnosis, prognosis, and treatment of certain disorders. Moreover, ECG data obtained through ambulatory monitoring, when combined with additional physiological data, can be especially helpful when diagnosing athletes, who present unique concerns not generally observed in a non-physically active patient population. For example, blood sugar plays a strong role in athletic performance and recovery and correlates with cardiac function. Monitoring respiratory and ECG together can help in diagnosing cardiorespiratory conditions common to athletes, especially since such conditions not only impair performance, but when combined with overtraining, a cardiorespiratory impairment may lead to severe or even terminal conditions, including severe bronchoconstriction or sudden death.
Existing portable devices that monitor cardiac data and other physiological data, at best, provide suboptimal results. Such devices can be inconvenient and may restrain movement; for example, a Holter device, which is a wearable ECG monitor with leads placed in a similar position as used with a standard ECG set-up, is cumbersome, expensive, typically only available by medical prescription, and requires skilled medical staff to properly position the electrodes.
Wrist monitors, such as the Fitbit product line of activity trackers, manufactured by Fitbit Inc., San Francisco, Calif., and related technologies, like wristwatch smartphones (also known as smartwatches), such as the Apple Watch, manufactured by Apple Inc., Cupertino, Calif. or the Gear S smartwatch, manufactured by Samsung Electronics Co., Ltd., Suwon, South Korea, as well as clothing embedded with sensors, such as the Hexoskin product line of wearable clothing, manufactured by Carré Technologies, Inc., Montreal, Quebec, Canada, all experience fidelity problems related to variation in electrode and sensor contact. Gaps in signal quality or interruptions or distortions of the data stream can lead to false positives and false negatives critical to understanding the relationship between physiological markers and medical events or needs.
U.S. Pat. No. 8,668,653, to Nagata, et al., discloses an ECG-monitoring shirt with a plurality of electrodes, including four limb electrodes and sensors disposed on a beltline. To fit each of the electrodes on the body surface of the examinee, a low-irritant acrylic adhesive, for example, may be applied on each of the electrodes that fit on the body's surface. The use of adhered electrodes is incompatible in patients with a predisposition to skin irritation.
Therefore, a need remains for an ambulatory, extended-wear monitor that can be used by patients who are intolerant to adhesively-adhered electrodes; highly mobile individuals, such as athletes, whose movement will cause adhesively-adhered electrodes to become dislodged; and individuals of all types in whom the recording high-quality PQRSTU ECG data and related physiological data are desired.
Long-term extended ECG monitoring can be provided through a form of ECG or physiological sensor embedded into clothing, rather than on the-skin electrodes. The garment is made of a material holding the sensor in place during extended wear through, for example, a compressible, breathable fabric. Electrodes are preferably placed on the garment to contact the skin along a wearer's sternal midline at specific positions to enhance P-wave detection and ECG. The electrodes are connected to an ECG monitor recorder that is either discrete from or affixed to the garment and obtains physiological telemetry through a wireless or electrical interface. Various types of physiological sensors can be provided.
One embodiment provides a wearable electrocardiography monitoring ensemble. A first receptacle is defined in a wearable garment by two horizontal bands placed across the wearable garment. A second receptacle is defined by two further horizontal bands positioned across the wearable garment and under the first receptacle. A first electrode assembly is positioned within the first receptacle and includes a backing with an electrical connection having an electrode on one end of the electrical connection and terminated at the other end of the electrical connection to connect with a monitor recorder. A second electrode assembly is positioned within the second receptacle and includes a backing with an electrical connection having an electrode on one end of the electrical connection and terminated at the other end of the electrical connection to connect with a further monitor recorder. The first and second electrodes are aligned longitudinally in the wearable garment.
The wearable monitoring ensemble creates a more natural experience for wearers and can be used to produce an expanded dataset for diagnosis because the ensemble can collect data during activities of daily living and can capture cardiovascular events outside of clinical observation, which is otherwise not practicable, especially for athletes.
Still other embodiments will become readily apparent to those skilled in the art from the following detailed description, wherein are described embodiments by way of illustrating the best mode contemplated. As will be realized, other and different embodiments are possible, and the embodiments' several details are capable of modifications in various obvious respects, all without departing from their spirit and the scope. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not as restrictive.
Physiology monitoring can be provided through a wearable monitor that includes two components, a flexible extended wear electrode patch and a removable reusable monitor recorder.
The placement of the wearable monitor 12 in a location at the sternal midline 16 (or immediately to either side of the sternum 13) significantly improves the ability of the wearable monitor 12 to cutaneously sense cardiac electric signals, particularly the P-wave (or atrial activity) and, to a lesser extent, the QRS interval signals in the ECG waveforms that indicate ventricular activity. The sternum 13 overlies the right atrium of the heart and the placement of the wearable monitor 12 in the region of the sternal midline 13 puts the ECG electrodes of the electrode patch 15 in a location better adapted to sensing and recording P-wave signals than other placement locations, say, the upper left pectoral region. In addition, placing the lower or inferior pole (ECG electrode) of the electrode patch 15 over (or near) the Xiphoid process and lower sternum facilitates sensing of right ventricular activity and provides superior recordation of the QRS interval.
During use, the electrode patch 15 is first adhered to the skin along the sternal midline 16 (or immediately to either side of the sternum 13). A monitor recorder 14 is then snapped into place on the electrode patch 15 to initiate ECG monitoring.
The electrode patch 15 incorporates features that significantly improve wearability, performance, and comfort throughout an extended monitoring period. The entire electrode patch 15 is lightweight in construction, which reduces shear forces and allows the patch to be resilient to disadhesing, displacement, or falling off and, critically, to avoid creating distracting discomfort, even when a person is asleep. In contrast, the weight of a heavy ECG monitor impedes wearer mobility and will cause the monitor to constantly tug downwards and press on the wearer's body; frequent adjustments by the wearer are needed to maintain comfort.
During every day wear, the electrode patch 15 is subjected to pushing, pulling, and torsional movements, including compressional and torsional forces when the wearer bends forward, and tensile and torsional forces when the wearer leans backwards. To counter these stress forces, the electrode patch 15 incorporates crimp and strain reliefs, as further described infra respectively with reference to
The monitor recorder 14 removably and reusably snaps into an electrically non-conductive receptacle 25 during use. The monitor recorder 14 contains electronic circuitry for recording and storing the wearer's electrocardiography as sensed via a pair of ECG electrodes provided on the electrode patch 15, such as described in commonly-assigned U.S. Pat. No. 9,730,593, the disclosure of which is incorporated by reference. The circuitry includes a microcontroller, flash storage, ECG signal processing, analog-to-digital conversion (where applicable), and an external interface for coupling to the electrode patch 15 and to a download station for stored data download and device programming. The monitor recorder 14 also includes external wearer-interfaceable controls, such as a push button to facilitate event marking and provide feedback. In a further embodiment, the circuitry, with the assistance of the appropriate types of deployed electrodes or sensors, is capable of monitoring other types of physiology, in addition to ECGs. Still other types of monitor recorder components and functionality are possible.
The non-conductive receptacle 25 is provided on the top surface of the flexible backing 20 with a retention catch 26 and tension clip 27 molded into the non-conductive receptacle 25 to conformably receive and securely hold the monitor recorder 14 in place. The edges of the bottom surface of the non-conductive receptacle 25 are preferably rounded, and the monitor recorder 14 is nestled inside the interior of the non-conductive receptacle 25 to present a rounded (gentle) surface, rather than a sharp edge at the skin-to-device interface.
The electrode patch 15 is intended to be disposable. The monitor recorder 14, however, is reusable and can be transferred to successive electrode patches 15 to ensure continuity of monitoring. The placement of the wearable monitor 12 in a location at the sternal midline 16 (or immediately to either side of the sternum 13) benefits long-term extended wear by removing the requirement that ECG electrodes be continually placed in the same spots on the skin throughout the monitoring period. Instead, the wearer is free to place an electrode patch 15 anywhere within the general region of the sternum 13.
As a result, at any point during ECG monitoring, the wearer's skin is able to recover from the wearing of an electrode patch 15, which increases wearer comfort and satisfaction, while the monitor recorder 14 ensures ECG monitoring continuity with minimal effort. A monitor recorder 14 is merely unsnapped from a worn out electrode patch 15, the worn out electrode patch 15 is removed from the skin, a new electrode patch 15 is adhered to the skin, possibly in a new spot immediately adjacent to the earlier location, and the same monitor recorder 14 is snapped into the new electrode patch 15 to reinitiate and continue the ECG monitoring.
During use, the electrode patch 15 is first adhered to the skin in the sternal region.
In addition, a battery compartment 36 is formed on the bottom surface of the non-conductive receptacle 25. A pair of battery leads (not shown) from the battery compartment 36 to another pair of the electrical pads 34 electrically interface the battery to the monitor recorder 14. The battery contained within the battery compartment 35 can be replaceable, rechargeable or disposable.
The monitor recorder 14 draws power externally from the battery provided in the non-conductive receptacle 25, thereby uniquely obviating the need for the monitor recorder 14 to carry a dedicated power source. The battery contained within the battery compartment 36 can be replaceable, rechargeable or disposable. In a further embodiment, the ECG sensing circuitry of the monitor recorder 14 can be supplemented with additional sensors, including an SpO2 sensor, a blood pressure sensor, a temperature sensor, respiratory rate sensor, a glucose sensor, an air flow sensor, and a volumetric pressure sensor, which can be incorporated directly into the monitor recorder 14 or onto the non-conductive receptacle 25.
The placement of the flexible backing 20 on the sternal midline 16 (or immediately to either side of the sternum 13) also helps to minimize the side-to-side movement of the wearable monitor 12 in the left- and right-handed directions during wear. However, the wearable monitor 12 is still susceptible to pushing, pulling, and torquing movements, including compressional and torsional forces when the wearer bends forward, and tensile and torsional forces when the wearer leans backwards. To counter the dislodgment of the flexible backing 20 due to compressional and torsional forces, a layer of non-irritating adhesive, such as hydrocolloid, is provided at least partially on the underside, or contact, surface of the flexible backing 20, but only on the distal end 30 and the proximal end 31. As a result, the underside, or contact surface of the longitudinal midsection 23 does not have an adhesive layer and remains free to move relative to the skin. Thus, the longitudinal midsection 23 forms a crimp relief that respectively facilitates compression and twisting of the flexible backing 20 in response to compressional and torsional forces. Other forms of flexible backing crimp reliefs are possible.
Unlike the flexible backing 20, the flexible circuit 32 is only able to bend and cannot stretch in a planar direction.
The flexible circuit 32 can be provided either above or below the flexible backing 20.
The electrode patch 15 is intended to be a disposable component, which enables a wearer to replace the electrode patch 15 as needed throughout the monitoring period, while maintaining continuity of physiological sensing through reuse of the same monitor recorder 14.
As described supra with reference to
A pair of openings 46 is defined on the distal and proximal ends of the wearable material 44 and layer 43 of non-irritating adhesive for ECG electrodes 38, 39 (shown in
The non-conductive receptacle 25 includes a main body 54 that is molded out of polycarbonate, ABS, or an alloy of those two materials to provide a high surface energy to facilitate adhesion of an adhesive seal 53. The main body 54 is attached to a battery printed circuit board 52 by the adhesive seal 53 and, in turn, the battery printed circuit board 52 is adhered to the flexible circuit 47 with an upper flexible circuit seal 50. A pair of conductive transfer adhesive points 51 or, alternatively, soldered connections, or electromechanical connections, including metallic rivets or similar conductive and structurally unifying components, connect the circuit traces 33, 37 (shown in
In a still further embodiment, the flexible circuit 32 (shown in
To form a distal electrode assembly, a distal wire 61 is interlaced into the distal end 30 of the flexible backing 20, continues along an axial path through the narrow longitudinal midsection of the elongated strip, and electrically connects to the battery printed circuit board 62 on the proximal end 31 of the flexible backing 20. The distal wire 61 is connected to the battery printed circuit board 62 by stripping the distal wire 61 of insulation, if applicable, and interlacing or sewing the uninsulated end of the distal wire 61 directly into an exposed circuit trace 63. The distal wire-to-battery printed circuit board connection can be made, for instance, by back stitching the distal wire 61 back and forth across the edge of the battery printed circuit board 62. Similarly, to form a proximal electrode assembly, a proximal wire (not shown) is interlaced into the proximal end 31 of the flexible backing 20. The proximal wire is connected to the battery printed circuit board 62 by stripping the proximal wire of insulation, if applicable, and interlacing or sewing the uninsulated end of the proximal wire directly into an exposed circuit trace 64. The resulting flexile wire connections both establish electrical connections and help to affix the battery printed circuit board 62 to the flexible backing 20.
The battery printed circuit board 62 is provided with a battery compartment 36. A set of electrical pads 34 are formed on the battery printed circuit board 62. The electrical pads 34 electrically interface the battery printed circuit board 62 with a monitor recorder 14 when fitted into the non-conductive receptacle 25. The battery compartment 36 contains a spring 65 and a clasp 66, or similar assembly, to hold a battery (not shown) in place and electrically interfaces the battery to the electrical pads 34 through a pair battery leads 67 for powering the electrocardiography monitor 14. Other types of battery compartment are possible. The battery contained within the battery compartment 36 can be replaceable, rechargeable, or disposable.
In a yet further embodiment, the circuit board and non-conductive receptacle 25 are replaced by a combined housing that includes a battery compartment and a plurality of electrical pads. The housing can be affixed to the proximal end of the elongated strip through the interlacing or sewing of the flexile wires or other wires or threads.
The core of the flexile wires may be made from a solid, stranded, or braided conductive metal or metal compounds. In general, a solid wire will be less flexible than a stranded wire with the same total cross-sectional area, but will provide more mechanical rigidity than the stranded wire. The conductive core may be copper, aluminum, silver, or other material. The pair of the flexile wires may be provided as insulated wire. In one embodiment, the flexile wires are made from a magnet wire from Belden Cable, catalogue number 8051, with a solid core of AWG 22 with bare copper as conductor material and insulated by polyurethane or nylon. Still other types of flexile wires are possible. In a further embodiment, conductive ink or graphene can be used to print electrical connections, either in combination with or in place of the flexile wires.
In a still further embodiment, the flexile wires are uninsulated.
Both end portions of the pair of flexile wires are typically placed uninsulated on the contact surface of the flexible backing 20 to form a pair of electrode signal pickups.
In a still yet further embodiment, the flexile wires are left freely riding on the contact surfaces on the distal and proximal ends of the flexible backing, rather than being interlaced into the ends of the flexible backing 20.
The distal wire 61 is interlaced or sewn through the longitudinal midsection of the flexible backing 20 and takes the place of the flexible circuit 32.
The distal wire 61 is flexile yet still retains a degree of rigidity that is influenced by wire gauge, composition, stranding, insulation, and stitching pattern. For example, rigidity decreases with wire gauge; and a solid core wire tends to be more rigid than a stranded core of the same gauge. The combination of the flexibility and the rigidity of the portion of the distal wire 61 located on or close to the midsection contributes to the overall strength and wearability of the patch.
The interlacing of the distal wire 61 through the narrow longitudinal midsection 22 of the flexible backing 20 bends the distal wire 61 into a line of rounded stitches that alternate top and bottom, which can be advantageous to long term wearability. First, the tension of the rounded stitches reinforces the planar structure of the narrow longitudinal midsection 22 and spreads a dislodging force impacting on one end of the flexible backing 20 to the other end of the flexible backing 20. Second, the rounded stitches leave room for stretching, compressing, bending, and twisting, thus increasing the wearability of the patch extended wear electrode patch 15 by facilitating extension, compression, bending, and twisting of the narrow longitudinal midsection 22 in response to tensile, compressional, bending, and torsional forces.
In a further embodiment, the distal wire and the proximal wire may be stitched or sewn into the flexible backing 20. Depending upon the type of stitching used, the distal or proximal wire may use more than one individual wire. For instance, a conventional sewing machine used to stitch fabrics uses a spool of thread and a bobbin, which are both wound with thread that together allow the creation of various stitching patterns, such as the lockstitch. Other type of stitching patterns are possible. Additionally, where more than one “threads” are used for stitching, the flexile wire may constitute all of the “threads,” thereby increasing redundancy of the circuit trace thus formed. Alternatively, just one (or fewer than all) of the threads may be conductive, with the non-conductive threads serving to reinforce the strength of the flexile wire connections and flexible backing 20. The additional threads can be made from line, threads, or fabrics of sufficient mechanical strength and do not need to be conductive; alternatively, the same flexile wires can be employed to serve as the additional threads.
Conventionally, flexible circuits, such as the flexible circuit 32 (shown in
Manufacturing a flexible circuit typically requires the use of sophisticated and specialized tools, coupled with environmentally unfriendly processes, including depositing copper on a polyamide core, etching away unwanted copper with inline etching or an acid bath to retain only the desired conductive circuit traces, and applying a coverlay to the resulting flexible circuit. Significant amounts of hazardous waste are generated by these subtractive processes during the fabrication of each flexible circuit. Properly disposing of such hazardous waste is expensive and adds to the costs of the flexible circuit.
In the still further embodiment described supra beginning with reference to
The general manner of constructing the electrode assembly can be applied to other forms of electronic components in which custom point-to-point circuit traces need to be affixed to a gauze or textile backing, as well as backings made from other materials. The circuit traces are replaced by the interlaced or sewn flexile wires, and the ends of each flexile wire are terminated, as appropriate to the application. The flexile wires may, by example, connect two circuit boards, or connect to an electrical terminal, power source, or electrical component. In addition, flexile wires may be used to replace a printed circuit board entirely, with each flexile wire serving as a form of sewn interconnect between two or more discrete components, including resistors, capacitors, transistors, diodes, operational amplifiers (op amps) and other integrated circuits, and other electronic or electromechanical components.
By way of illustration, the flexile wires will be described as terminated for use in an electrode assembly, specifically, as terminated on one end to form an electrode signal pickup and on the other end to connect into a circuit board. Constructing the electrode assembly entails interlacing, including manually threading, or machine sewing the flexile, conductive wire through the flexible backing 20.
As an initial step, a backing is cut to shape and, if required, holes are cut at regularly-spaced intervals along an axial path (step 91) through which the flexile wire will be interlaced. Holes will need to be cut, for instance, if the flexile wire is to be hand-guided through the backing, or where the backing is cut from a material that is difficult to puncture with a threaded needle, such as used by a sewing machine. In one embodiment, the backing is cut from wearable gauze, latex, woven textile, or similar wrap knit or stretchable and wear-safe material, such as a Tricot-type linen; the resulting backing is flexible and yielding. The backing is also cut into an elongated “hourglass”-like shape, when viewed from above, with a pair of cut-outs and a longitudinal midsection that together help minimize interference with and discomfort to breast tissue, particularly in women (and gynecomastia men), such as described supra with reference to
The flexile wire is then interlaced or sewn into the backing (step 92). Interlacing can be performed by a machine that guides the flexile wire through the holes previously cut in the material in a crisscrossed, interwoven, or knitted fashion, as well as by hand. The flexile wire can also be guided through the backing without first cutting holes, provided that the weave of the material is sufficiently loose to allow passage of the flexile wire if the flexile wire is otherwise incapable of passing through the backing without the assistance of a needle or other piercing instrument.
Alternatively, the flexile wire could be sewn into the backing by using the flexile wire as “thread” that is stitched into place using a needle or similar implement. If a single flexile wire is employed, the stitching will be a line of rounded stitches that alternate top and bottom, as described supra; however, if more than one flexile wire is used, or the stitching pattern requires the use of more than one thread, other forms of conventional machine-stitching patterns could be employed, such as a lockstitch.
Once completed, the interlacing or sewing of the flexile wire into the backing creates an integrated point-to-point electrical path that takes the place of a custom circuit trace using an additive, rather than subtractive, manufacturing process. The flexile wire can be interlaced or sewn along a straight, curved, or arbitrary path. One flexile wire is required per point-to-point circuit trace. The strength and pliability of the flexile wire reinforces the backing and, in the still further embodiment described supra beginning with reference to
The flexile wire itself may be insulated or bare (step 93). When one end of the flexile wire is connected to (or forms) an electrode, particularly a dermal physiology electrode that senses electrical potentials on the skin's surface, insulated flexile wire will ordinarily be used, with only a portion of the flexile wire incident to the electrode stripped of insulation. However, bare uninsulated flexile wire could alternatively be used throughout, so long as those portions of the uninsulated flexile wire that are exposed on the contact-facing surface of the backing are insulated and shielded from electrical contact (step 94), such as by applying a layer of plastic, rubber-like polymers, or varnish, or by an additional layer of gauze or adhesive (or non-adhesive) gel over the exposed wire. The uninsulated flexile wire exposed on other surfaces of the backing could also be insulated or simply be left bare.
One end of the flexile wire may be terminated as an electrode signal pickup (step 95). If insulated flexile wire is used, a portion of the end of the flexile wire is stripped of insulation (step 96) using, for instance, a wire stripper or plasma jet. The electrode signal pickup could either be formed by interlacing (or sewing) the flexile wire (step 97) into the backing in the shape of the desired electrode (step 98) or positioned over the contact-facing area of the backing designated to serve as an electrode signal pickup and embedded within an electrically conductive adhesive (step 99). In a yet further embodiment, the flexile wire could be terminated as a connection to a discrete electrode, such as by sewing an uninsulated portion of the end of the electrode wire into the discrete electrode to thereby establish an electrical contact and affix the discrete electrode to the backing. The Universal ECG EKG electrode, manufactured by Bio Protech Inc., Tustin, Calif., is one example of a discrete electrode.
Finally, the other end of the flexile wire may be terminated as a connection to a circuit board (step 100). The flexile wire can be interlaced or sewn onto the circuit board, for instance, by back stitching the flexile wire back and forth across the edge of the circuit board to thereby establish an electrical contact and affix the discrete electrode to the backing.
In a further embodiment, flexile wire can be used to replace all or part of a printed circuit board, such as battery printed circuit board 62 used in constructing a stress-pliant physiological electrode assembly, as described supra, or for any other application that requires interconnection of electrical or electro mechanical components on a physical substrate or backing. Flexile wire in place of conductive circuit traces can work especially well with simple circuit board layouts, where ample space between components and relatively uncomplicated layouts are amenable to stitched-in interconnections. In addition, the use of flexile wire can simplify circuit layout design in multilayer circuits, as insulated flexile wires can be run across each other in situations that would otherwise require the use of a multilayer printed circuit board or similar solution.
Through such use of flexile wire, a printed circuit board can be omitted in whole or in part. Interconnects between and connections to the electronic and electro mechanical components formerly placed on the printed circuit board can instead be sewn from flexile wire. For instance, the battery printed circuit board 62 can be replaced by flexile wire interconnects that connect the electrodes to a sewn set of electrical pads formed by over-stitching the flexile wire into electrical contact surfaces of sufficient size to interface with a monitor recorder 14 when fitted into the non-conductive receptacle 25. Likewise, the spring 65 and clasp 66 can be sewn in place using flexile wire to hold a battery in place with flexile wire interconnects connecting the battery to a sewn set of electrical pads formed by over-stitching the flexile wire into electrical contact surfaces of sufficient size to interface with a monitor recorder 14 when fitted into the non-conductive receptacle 25. Still other approaches to replacing printed circuit boards with flexile wire interconnects are possible.
The resultant stress-pliant physiological electrode assembly may be electrically coupled to a broad range of physiological monitors not limited to electrocardiographic measurement. The foregoing method of constructing a stress-pliant electrode assembly is adaptable to manufacturing other forms of dermal electrodes, including electrodes for electrocardiography, electroencephalography, and skin conductance measurements. Further, by adjusting the number of electrodes, the distances among the electrode signal pickups, and the thickness of the flexile wire, the method can be adapted to manufacturing at low cost an electrode assembly that is lightweight and resistant to tensile, compressional and torsional forces, thus contributing to long-term wear and versatility.
The extended wear electrocardiography monitor, described supra with reference to
As an alternative to an adhesively-attached electrode patch, the electrodes of the extended wear electrocardiography monitor can be integrated into a wearable garment that can be coupled with a monitor recorder 14 (shown in
An electrode patch achieves fully continuous electrode contact through an adhesive or a fixing agent that adheres a gauze or similarly-woven or flexible material against the skin; the gauze serves as a backing to each electrode, which is held captive and firmly in place between the skin and the gauze. In addition, the electrodes themselves could be coated with an adhesive to self-adhere the electrodes directly to the skin. In both forms, the presence of adhesive on the skin's surface can be at variance with extended long-term wear, especially on patients with sensitive or fragile skin or who have allergies or sensitivities to the chemicals or materials used in adhesive patches.
The construction of the wearable garment 301 employs an internal structure 302 that obviates the need to use adhesives or other fixing agents to hold electrophysiology and physiology sensing electrodes into place. The internal structure 302 allows the wearable garment 301 to exert a compressive force against an electrode assembly 313 that is sufficient to keep the electrodes 309 and 310 in usably-continuous contact with the wearer's skin throughout the monitoring period. The electrode assembly 313 contains at least two electrodes 309 and 310 that are both affixed to a backing, either individually or combined. The electrode assembly 313 is provided on an inside-facing surface of the wearable garment 301 on an underside of the internal structure 302 to keep the electrode assembly 313 firmly against the wearer's skin. In contrast to an electrode-equipped adhesive patch, the wearable garment 301 permits unconstrained free movement during monitoring and the wearer is typically unaware of the presence of the electrode assembly 313. However, to effectively measure electrophysiology, the electrodes 309 and 310 need to be kept in fairly continuous, albeit not absolutely constant, physical contact with the skin.
The wearable monitoring ensemble 300 obviates the necessity of adhesives or other fixing agents that adhere directly to the skin by utilizing the internal structure 302 of the wearable garment 301 to place and retain the electrode assembly 313 securely against the skin. To some degree, internal structure 302 inherent in the overall design of the wearable garment 301, when in the form of clothing worn about the torso, specifically, a shirt, blouse, or tunic, will retain the relative positions of the various panels that make up the wearable garment 301 in place during wear. Elements of the inherent garment design include, for instance, the openings for the arms 303a and 303b, the neck 304, and torso 305 proper. Other elements of inherent garment design are possible.
To facilitate monitoring purposes, though, the relative position of the panel upon which the sensory assembly 313 is affixed to the internal structure 302 on the inside surface of the wearable garment 301 must be kept from dramatically shifting about; the location of the electrode assembly 313 ought to be sufficiently stable, so as to avoid displacing the underlying electrodes 309 and 310 to the degree that cardiac electric potential signals are degraded or change character.
The inherent design of the wearable garment 301 only provides a partial solution and these structures alone will not suffice to maintain the electrode assembly 313 in fairly continuous physical contact with the skin. The internal structure 302 of the wearable garment 301 is biased to press snuggly against the skin in at least those portions of the wearable garment 301 where the electrode assembly 313 need be held in a relatively stable orientation. The compressive bias is provided by the compressible and elastomeric material and the internal structure 302, which can include elastic bands 306a, 306b, 306c, and 306d, embedded longitudinally across the chest, or by a combination of fabric components with varying characteristics of elasticity.
The compressive force imparted by the wearable garment 301 on the electrode assembly 313 is provided by placing the electrode assembly 313 on an inside surface of the wearable garment 301 on an underside of the internal structure 302, such that the electrode assembly 313 is firmly “pinned” in place against the skin, yet not adhered. The amount of side-to-side shift or momentary loss of contact that can be tolerated without signal degradation or compromise depends upon the monitoring location. For instance, to optimize capture of P-wave signals, the electrode assembly 313 can advantageously be positioned axially along the midline of a wearer's sternum, such as described in commonly-assigned U.S. Pat. No. 9,700,227, the disclosure of which is incorporated by reference. To secure the electrode assembly 313 in the desired orientation axially along the sternal midline, the wearable garment 301 integrates a bias that imparts compressive force circumferentially about the wearer's torso; the compressive force is sufficient to keep the two electrodes 309 and 310 against the skin for the majority of the time during wear and monitoring. However, whereas an electrode patch seeks to keep the electrodes in continuous and stationary contact with the skin at all times, the electrodes here are permitted to actively “float” over the skin's surface, so long at least a part of an electrode's surface contacts the skin. Thus, to a limited extent, the electrodes 309 and 310 can slide around the general region on the skin where a cardiac electric potential signal sensing is desired. In addition, the occasional loss of signal pick up that can occur if the electrode assembly 313 briefly loses contact with the skin, such as happens if the wearer makes a sudden movement, can be weathered; cardiac electric potential signals lost through a momentary loss of skin contact are not likely to adversely degrade overall signal fidelity, so long as the loss of contact is sufficiently brief and spans say, no more than a few heartbeats. As a result, the wearable garment 301 needs to keep the electrode assembly 313 oriented on the skin in the same overall spot, but the electrode assembly 313 need not be fixed as an absolutely stationary location and some degree of sliding movement or “float” along the skin's surface is permissible.
The electrode assembly 313 is also provided with two electrical connections 311 and 312 through which a monitor recorder can receive and record electrical potential signals. One end of each of the electrical connections 311 and 312 is connected to one of the electrodes 309 and 310, while the other end of each of the electrical connections 311 and 312 is terminated to suit interfacing with a compatible form of monitor recorder. In one embodiment, the electrical connections 311 and 312 can be connected to the pair of electrical pads 34 provided on the non-conductive receptacle 25 (shown in
The electrode assembly 313 can be packaged in at least three different forms, including a flexible circuit electrode assembly and flexile wire electrode assemblies with discrete or sewn-in electrodes. These forms of sensor assemblies will now be discussed. First,
Second, the two flexible circuits 314 and 315 can be replaced with a pair of flexile wires that are sewn or stitched into a pair of discrete electrodes, such as described supra with reference to
Finally, both the two flexible circuits 314 and 315 and the two electrodes 309 and 310 can be respectively replaced with a pair of flexile wires and a pair of sewn-in electrodes.
The wearable monitoring ensemble 300 is advantageous for both patients and athletes because the ambulatory apparatus can collect high-quality ECG and physiological data while the wearer engages in activities of daily living. ECG data are crucial for diagnosing many cardiovascular conditions, but additional data are often necessary for differential diagnoses, such as in diabetic and hypertensive patients. Cardiovascular patients must take particular care in monitoring their status to avoid related adverse events; for example, monitoring temperature can be helpful in cardiovascular patients because cardiovascular system compromises patients' capacity for maintaining a normal body temperature, and cardiovascular patients may be more susceptible to hypothermia in cool environments.
Athletes also benefit from ECG data combined with additional physiological data to prevent adverse cardiac events, including power sports athletes, aged athletes, and young athletes with congenital heart conditions. Moreover, ECG data combined with other physiological data may aid athletes in optimizing performance. In many instances, blood sugar measurements may aid in generating a diagnosis, prognosis, and treatment plan as well as predicting athletic performance. For example, patients with diabetes or blood sugar levels that are greater than normal are also more likely to develop certain heart diseases, such as ischemic heart disease and myocardial infarction. Moreover, multiple types of physiological data may be combined to predict additional disease conditions, such as the combination of high blood pressure, coronary heart disease, and diabetes, which can severely damage cardiac muscle and lead to heart failure. In addition, blood sugar plays a strong role in athletic performance and recovery; thus, athletes benefit from both monitoring their blood sugar before, during, and after exercise as well as using the monitoring data to elucidate undiagnosed blood sugar conditions. For example, exercise-induced hypoglycemia can severely hamper performance and may indicate a more serious condition that can lead to sudden death.
Monitoring blood pressure may also be key to elucidating a patient's or athlete's underlying physical condition. Hypertension is the greatest risk factor for cardiovascular disease in both normal and athlete populations. Dubbed the “silent killer,” hypertension is both common as well as under-diagnosed and can damage various organs, leading to a higher risk of left ventricular hypertrophy and sudden death, among other conditions. Further, combined with ECG data, it may provide critical data for determining a patient's cardiovascular condition. For example, as noted above, heart failure is more likely in patients with high blood pressure combined with heart disease and blood sugar dysregulation. Further, silent ischemia is often diagnosed through detecting hypertension and ST depression, which is best observed using an ambulatory ECG device; a combined prolonged QT interval and hypertension are associated with increased risk of pathological cardiovascular conditions, including the risk of sudden death; and hypertensive patients with abnormal T wave patterns exhibit increased left ventricular mass, which enhances the risk of adverse cardiac events, including sudden death. Moreover, while the athletic population maintains a lower blood pressure generally, hypertension remains the greatest cardiac risk factor for athletes. Further, athletes benefit from blood pressure monitoring, particularly during exercise, because untreated hypertension can significantly impair athletic performance; moreover, older athletes are at particular risk for undiagnosed hypertension.
Further, detecting abnormal respiratory function may facilitate diagnosis, prognosis, and treatment of certain disorders in both patients and athletes. For example, Cheyne-Stokes breathing associated with chronic heart failure is a predictor of poor prognoses associated with cardiac death. In addition, cardiorespiratory conditions are common in athletes but are often undiagnosed. Such conditions not only impair performance, but overtraining with a cardiorespiratory may lead to severe consequences, such as sudden death due to severe bronchoconstriction. Further, sleep decreases the diagnostic efficacy of ECG monitoring alone due to natural heart rate decrease during sleep. As a patient enters non-rapid eye movement (NREM) sleep, the patient undergoes physiological changes due to less sympathetic nervous system activity. Thus, even healthy people may experience sinus bradyarrhythmia during sleep, and ECG monitoring alone may reveal whether the bradyarrhythmia is natural or due to a pathological condition, such as an apnea. Further, if a patient experiences other types of arrhythmias during sleep, a physician may not be able to determine whether an arrhythmia is due to sleep apnea or other morbidity without measuring the patient's air flow, which is the flow of air in and out of the patient's lungs during breathing, or other respiration indicator. However, considering that cardiac manifestations of sleep apnea are most apparent at night, short-term ECG monitoring during business hours may not reveal cardiac arrhythmia.
While the invention has been particularly shown and described as referenced to the embodiments thereof, those skilled in the art will understand that the foregoing and other changes in form and detail may be made therein without departing from the spirit and scope.
This non-provisional patent application is a continuation of, U.S. Pat. No. 10,251,575, issued Apr. 9, 2019, which is a continuation of U.S. Pat. No. 9,655,537, issued May 23, 2017, which is a continuation-in-part of U.S. Pat. No. 9,717,432, issued Aug. 1, 2017, which is a continuation-in-part of U.S. Pat. No. 9,545,204, issued Jan. 17, 2017, and further claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Patent application, Ser. No. 61/882,403, filed Sep. 25, 2013, the disclosures of which are incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
3215136 | Holler et al. | Nov 1965 | A |
3569852 | Berkovits | Mar 1971 | A |
3602215 | Parnell | Aug 1971 | A |
3699948 | Ota et al. | Oct 1972 | A |
3718772 | Sanctuary | Feb 1973 | A |
3893453 | Goldberg | Jul 1975 | A |
4123785 | Cherry et al. | Oct 1978 | A |
4151513 | Menken et al. | Apr 1979 | A |
4328814 | Arkans | May 1982 | A |
4441500 | Sessions et al. | Apr 1984 | A |
4532934 | Kelen | Aug 1985 | A |
4546342 | Weaver et al. | Oct 1985 | A |
4550502 | Grayzel | Nov 1985 | A |
4580572 | Granek et al. | Apr 1986 | A |
4635646 | Gilles et al. | Jan 1987 | A |
4653022 | Koro | Mar 1987 | A |
4716903 | Hansen | Jan 1988 | A |
4809705 | Ascher | Mar 1989 | A |
4915656 | Alferness | Apr 1990 | A |
5007429 | Treatch et al. | Apr 1991 | A |
5025794 | Albert et al. | Jun 1991 | A |
5107480 | Naus | Apr 1992 | A |
5168876 | Quedens et al. | Dec 1992 | A |
5215098 | Steinhaus | Jun 1993 | A |
5231990 | Gauglitz | Aug 1993 | A |
D341423 | Bible | Nov 1993 | S |
5263481 | Axelgaard | Nov 1993 | A |
5265579 | Ferrari | Nov 1993 | A |
5333615 | Craelius et al. | Aug 1994 | A |
5341806 | Gadsby et al. | Aug 1994 | A |
5348008 | Bornn et al. | Sep 1994 | A |
5355891 | Wateridge et al. | Oct 1994 | A |
5365934 | Leon et al. | Nov 1994 | A |
5365935 | Righter et al. | Nov 1994 | A |
5392784 | Gudaitis | Feb 1995 | A |
D357069 | Plahn et al. | Apr 1995 | S |
5402780 | Faasse, Jr. | Apr 1995 | A |
5402884 | Gilman et al. | Apr 1995 | A |
5450845 | Axelgaard | Sep 1995 | A |
5451876 | Sendford et al. | Sep 1995 | A |
5458141 | Neil | Oct 1995 | A |
5473537 | Glazer et al. | Dec 1995 | A |
5483969 | Testerman et al. | Jan 1996 | A |
5511553 | Segalowitz | Apr 1996 | A |
5540733 | Testerman et al. | Jul 1996 | A |
5546952 | Erickson | Aug 1996 | A |
5549655 | Erickson | Aug 1996 | A |
5579919 | Gilman et al. | Dec 1996 | A |
5582181 | Ruess | Dec 1996 | A |
D377983 | Sabri et al. | Feb 1997 | S |
5601089 | Bledsoe et al. | Feb 1997 | A |
5623935 | Faisandier | Apr 1997 | A |
5682901 | Kamen | Nov 1997 | A |
5697955 | Stolte | Dec 1997 | A |
5724967 | Venkatachalam | Mar 1998 | A |
5749902 | Olsen et al. | May 1998 | A |
5788633 | Mahoney | Aug 1998 | A |
5817151 | Olsen et al. | Oct 1998 | A |
5819741 | Karlsson et al. | Oct 1998 | A |
5850920 | Gilman et al. | Dec 1998 | A |
D407159 | Roberg | Mar 1999 | S |
5876351 | Rohde | Mar 1999 | A |
5906583 | Rogel | May 1999 | A |
5951598 | Bishay et al. | Sep 1999 | A |
5957857 | Hartley | Sep 1999 | A |
5984102 | Tay | Nov 1999 | A |
6032064 | Devlin et al. | Feb 2000 | A |
6038469 | Karlsson et al. | Mar 2000 | A |
6101413 | Olson et al. | Aug 2000 | A |
6115638 | Groenke | Sep 2000 | A |
6117077 | Del Mar et al. | Sep 2000 | A |
6134479 | Brewer et al. | Oct 2000 | A |
6148233 | Owen et al. | Nov 2000 | A |
6149602 | Arcelus | Nov 2000 | A |
6149781 | Forand | Nov 2000 | A |
6188407 | Smith et al. | Feb 2001 | B1 |
D443063 | Pisani et al. | May 2001 | S |
6245025 | Torok et al. | Jun 2001 | B1 |
6246330 | Nielsen | Jun 2001 | B1 |
6249696 | Olson et al. | Jun 2001 | B1 |
D445507 | Pisani et al. | Jul 2001 | S |
6269267 | Bardy et al. | Jul 2001 | B1 |
6272385 | Bishay et al. | Aug 2001 | B1 |
6298255 | Cordero et al. | Oct 2001 | B1 |
6301502 | Owen et al. | Oct 2001 | B1 |
6304773 | Taylor et al. | Oct 2001 | B1 |
6304780 | Owen et al. | Oct 2001 | B1 |
6304783 | Lyster et al. | Oct 2001 | B1 |
6374138 | Owen et al. | Apr 2002 | B1 |
6381482 | Jayaraman et al. | Apr 2002 | B1 |
6416471 | Kumar et al. | Jul 2002 | B1 |
6418342 | Owen et al. | Jul 2002 | B1 |
6424860 | Karlsson et al. | Jul 2002 | B1 |
6427083 | Owen et al. | Jul 2002 | B1 |
6427085 | Boon et al. | Jul 2002 | B1 |
6454708 | Ferguson et al. | Sep 2002 | B1 |
6456872 | Faisandier | Sep 2002 | B1 |
6463320 | Xue et al. | Oct 2002 | B1 |
6546285 | Owen et al. | Apr 2003 | B1 |
6605046 | Del Mar | Aug 2003 | B1 |
6607485 | Bardy | Aug 2003 | B2 |
6611705 | Hopman et al. | Aug 2003 | B2 |
6671545 | Fincke | Dec 2003 | B2 |
6671547 | Lyster et al. | Dec 2003 | B2 |
6694186 | Bardy | Feb 2004 | B2 |
6704595 | Bardy | Mar 2004 | B2 |
6705991 | Bardy | Mar 2004 | B2 |
6719701 | Lade | Apr 2004 | B2 |
6754523 | Toole | Jun 2004 | B2 |
6782293 | Dupelle et al. | Aug 2004 | B2 |
6856832 | Matsumura | Feb 2005 | B1 |
6860897 | Bardy | Mar 2005 | B2 |
6866629 | Bardy | Mar 2005 | B2 |
6887201 | Bardy | May 2005 | B2 |
6893397 | Bardy | May 2005 | B2 |
6895261 | Palamides | May 2005 | B1 |
6904312 | Bardy | Jun 2005 | B2 |
6908431 | Bardy | Jun 2005 | B2 |
6913577 | Bardy | Jul 2005 | B2 |
6944498 | Owen et al. | Sep 2005 | B2 |
6960167 | Bardy | Nov 2005 | B2 |
6970731 | Jayaraman et al. | Nov 2005 | B1 |
6978169 | Guerra | Dec 2005 | B1 |
6993377 | Flick et al. | Jan 2006 | B2 |
7020508 | Stivoric et al. | Mar 2006 | B2 |
7027864 | Snyder et al. | Apr 2006 | B2 |
7065401 | Worden | Jun 2006 | B2 |
7085601 | Bardy et al. | Aug 2006 | B1 |
7104955 | Bardy | Sep 2006 | B2 |
7134996 | Bardy | Nov 2006 | B2 |
7137389 | Berthon-Jones | Nov 2006 | B2 |
7147600 | Bardy | Dec 2006 | B2 |
7215991 | Besson et al. | May 2007 | B2 |
7248916 | Bardy | Jul 2007 | B2 |
7257438 | Kinast | Aug 2007 | B2 |
7277752 | Matos | Oct 2007 | B2 |
7294108 | Bornzin et al. | Nov 2007 | B1 |
D558882 | Brady | Jan 2008 | S |
7328061 | Rowlandson et al. | Feb 2008 | B2 |
7412395 | Rowlandson et al. | Aug 2008 | B2 |
7429938 | Corndorf | Sep 2008 | B1 |
7552031 | Vock et al. | Jun 2009 | B2 |
D606656 | Kobayashi et al. | Dec 2009 | S |
7706870 | Shieh et al. | Apr 2010 | B2 |
7756721 | Falchuk et al. | Jul 2010 | B1 |
7787943 | McDonough | Aug 2010 | B2 |
7874993 | Bardy | Jan 2011 | B2 |
7881785 | Nassif et al. | Feb 2011 | B2 |
D639437 | Bishay et al. | Jun 2011 | S |
7959574 | Bardy | Jun 2011 | B2 |
8108035 | Bharmi | Jan 2012 | B1 |
8116841 | Bly et al. | Feb 2012 | B2 |
8135459 | Bardy et al. | Mar 2012 | B2 |
8172761 | Rulkov et al. | May 2012 | B1 |
8180425 | Selvitelli et al. | May 2012 | B2 |
8200320 | Kovacs | Jun 2012 | B2 |
8231539 | Bardy | Jul 2012 | B2 |
8231540 | Bardy | Jul 2012 | B2 |
8239012 | Felix et al. | Aug 2012 | B2 |
8249686 | Libbus et al. | Aug 2012 | B2 |
8260414 | Nassif et al. | Sep 2012 | B2 |
8266008 | Siegal et al. | Sep 2012 | B1 |
8277378 | Bardy | Oct 2012 | B2 |
8285356 | Bly et al. | Oct 2012 | B2 |
8285370 | Felix et al. | Oct 2012 | B2 |
8308650 | Bardy | Nov 2012 | B2 |
8366629 | Bardy | Feb 2013 | B2 |
8374688 | Libbus et al. | Feb 2013 | B2 |
8412317 | Mazar | Apr 2013 | B2 |
8460189 | Libbus et al. | Jun 2013 | B2 |
8473047 | Chakravarthy et al. | Jun 2013 | B2 |
8478418 | Fahey | Jul 2013 | B2 |
8538503 | Kumar et al. | Sep 2013 | B2 |
8554311 | Warner et al. | Oct 2013 | B2 |
8560046 | Kumar et al. | Oct 2013 | B2 |
8591430 | Amurthur et al. | Nov 2013 | B2 |
8594763 | Bibian et al. | Nov 2013 | B1 |
8600486 | Kaib et al. | Dec 2013 | B2 |
8613708 | Bishay et al. | Dec 2013 | B2 |
8613709 | Bishay et al. | Dec 2013 | B2 |
8620418 | Kuppuraj et al. | Dec 2013 | B1 |
8626277 | Felix et al. | Jan 2014 | B2 |
8628020 | Beck | Jan 2014 | B2 |
8668653 | Nagata et al. | Mar 2014 | B2 |
8684925 | Manicka et al. | Apr 2014 | B2 |
8688190 | Libbus et al. | Apr 2014 | B2 |
8718752 | Libbus et al. | May 2014 | B2 |
8744561 | Fahey | Jun 2014 | B2 |
8774932 | Fahey | Jul 2014 | B2 |
8790257 | Libbus et al. | Jul 2014 | B2 |
8790259 | Katra et al. | Jul 2014 | B2 |
8795174 | Manicka et al. | Aug 2014 | B2 |
8798729 | Kaib et al. | Aug 2014 | B2 |
8798734 | Kuppuraj et al. | Aug 2014 | B2 |
8818478 | Scheffler et al. | Aug 2014 | B2 |
8818481 | Bly et al. | Aug 2014 | B2 |
8823490 | Libbus et al. | Sep 2014 | B2 |
8938287 | Felix et al. | Jan 2015 | B2 |
8965492 | Baker et al. | Feb 2015 | B2 |
9066664 | Karjalainen | Jun 2015 | B2 |
9155484 | Baker et al. | Oct 2015 | B2 |
9204813 | Kaib et al. | Dec 2015 | B2 |
9241649 | Kumar et al. | Jan 2016 | B2 |
9259154 | Miller et al. | Feb 2016 | B2 |
9277864 | Yang et al. | Mar 2016 | B2 |
9339202 | Brockway et al. | May 2016 | B2 |
9375179 | Schultz et al. | Jun 2016 | B2 |
9414786 | Brockway et al. | Aug 2016 | B1 |
9439566 | Arne et al. | Sep 2016 | B2 |
9597004 | Hughes et al. | Mar 2017 | B2 |
9603542 | Veen et al. | Mar 2017 | B2 |
9700222 | Quinlan et al. | Jul 2017 | B2 |
9770182 | Bly et al. | Sep 2017 | B2 |
10034614 | Edic et al. | Jul 2018 | B2 |
10045708 | Dusan | Aug 2018 | B2 |
10049182 | Chefles et al. | Aug 2018 | B2 |
10251575 | Bardy | Apr 2019 | B2 |
20020013538 | Teller | Jan 2002 | A1 |
20020013717 | Ando et al. | Jan 2002 | A1 |
20020016798 | Sakai | Feb 2002 | A1 |
20020103422 | Harder et al. | Aug 2002 | A1 |
20020109621 | Khair et al. | Aug 2002 | A1 |
20020120310 | Linden et al. | Aug 2002 | A1 |
20020128686 | Minogue et al. | Sep 2002 | A1 |
20020184055 | Naghavi et al. | Dec 2002 | A1 |
20020193668 | Munneke | Dec 2002 | A1 |
20030004547 | Owen et al. | Jan 2003 | A1 |
20030028811 | Walker et al. | Feb 2003 | A1 |
20030073916 | Yonce | Apr 2003 | A1 |
20030083559 | Thompson | May 2003 | A1 |
20030097078 | Maeda | May 2003 | A1 |
20030139785 | Riff et al. | Jul 2003 | A1 |
20030176802 | Galen et al. | Sep 2003 | A1 |
20030211797 | Hill et al. | Nov 2003 | A1 |
20040008123 | Carrender | Jan 2004 | A1 |
20040019288 | Kinast | Jan 2004 | A1 |
20040034284 | Aversano et al. | Feb 2004 | A1 |
20040049120 | Cao et al. | Mar 2004 | A1 |
20040049132 | Barron et al. | Mar 2004 | A1 |
20040073127 | Istvan et al. | Apr 2004 | A1 |
20040087836 | Green et al. | May 2004 | A1 |
20040088019 | Rueter et al. | May 2004 | A1 |
20040093192 | Hasson et al. | May 2004 | A1 |
20040116784 | Gavish | Jun 2004 | A1 |
20040148194 | Wellons et al. | Jul 2004 | A1 |
20040163034 | Colbath et al. | Aug 2004 | A1 |
20040167416 | Lee | Aug 2004 | A1 |
20040207530 | Nielsen | Oct 2004 | A1 |
20040210165 | Marmaropoulos et al. | Oct 2004 | A1 |
20040236202 | Burton | Nov 2004 | A1 |
20040243435 | Williams | Dec 2004 | A1 |
20040256453 | Lammle | Dec 2004 | A1 |
20040260188 | Syed et al. | Dec 2004 | A1 |
20040260192 | Yamamoto | Dec 2004 | A1 |
20050010139 | Aminian et al. | Jan 2005 | A1 |
20050096717 | Bishay et al. | May 2005 | A1 |
20050108055 | Ott et al. | May 2005 | A1 |
20050151640 | Hastings | Jul 2005 | A1 |
20050154267 | Bardy | Jul 2005 | A1 |
20050182308 | Bardy | Aug 2005 | A1 |
20050182309 | Bardy | Aug 2005 | A1 |
20050215918 | Frantz et al. | Sep 2005 | A1 |
20050222513 | Hadley et al. | Oct 2005 | A1 |
20050228243 | Bardy | Oct 2005 | A1 |
20050245839 | Stivoric et al. | Nov 2005 | A1 |
20050261564 | Ryu | Nov 2005 | A1 |
20050275416 | Hervieux et al. | Dec 2005 | A1 |
20060025696 | Kurzweil et al. | Feb 2006 | A1 |
20060025824 | Freeman et al. | Feb 2006 | A1 |
20060030767 | Lang et al. | Feb 2006 | A1 |
20060030904 | Quiles | Feb 2006 | A1 |
20060041201 | Behbehani et al. | Feb 2006 | A1 |
20060084883 | Linker | Apr 2006 | A1 |
20060100530 | Kliot et al. | May 2006 | A1 |
20060111642 | Baura et al. | May 2006 | A1 |
20060122469 | Martel | Jun 2006 | A1 |
20060124193 | Orr et al. | Jun 2006 | A1 |
20060224072 | Shennib | Oct 2006 | A1 |
20060229522 | Barr | Oct 2006 | A1 |
20060235320 | Tan et al. | Oct 2006 | A1 |
20060253006 | Bardy | Nov 2006 | A1 |
20060264730 | Stivoric et al. | Nov 2006 | A1 |
20060264767 | Shennib | Nov 2006 | A1 |
20070003115 | Patton et al. | Jan 2007 | A1 |
20070038057 | Nam et al. | Feb 2007 | A1 |
20070050209 | Yered | Mar 2007 | A1 |
20070078324 | Wijisiriwardana | Apr 2007 | A1 |
20070078354 | Holland | Apr 2007 | A1 |
20070088406 | Bennett et al. | Apr 2007 | A1 |
20070089800 | Sharma | Apr 2007 | A1 |
20070093719 | Nichols, Jr. et al. | Apr 2007 | A1 |
20070100248 | Van Dam et al. | May 2007 | A1 |
20070100667 | Bardy | May 2007 | A1 |
20070123801 | Goldberger et al. | May 2007 | A1 |
20070131595 | Jansson et al. | Jun 2007 | A1 |
20070136091 | McTaggart | Jun 2007 | A1 |
20070179357 | Bardy | Aug 2007 | A1 |
20070185390 | Perkins et al. | Aug 2007 | A1 |
20070203415 | Bardy | Aug 2007 | A1 |
20070203423 | Bardy | Aug 2007 | A1 |
20070208232 | Kovacs | Sep 2007 | A1 |
20070208233 | Kovacs | Sep 2007 | A1 |
20070208266 | Hadley | Sep 2007 | A1 |
20070225611 | Kumar et al. | Sep 2007 | A1 |
20070244405 | Xue et al. | Oct 2007 | A1 |
20070249946 | Kumar et al. | Oct 2007 | A1 |
20070255153 | Kumar et al. | Nov 2007 | A1 |
20070265510 | Bardy | Nov 2007 | A1 |
20070276270 | Tran | Nov 2007 | A1 |
20070276275 | Proctor et al. | Nov 2007 | A1 |
20070293738 | Bardy | Dec 2007 | A1 |
20070293739 | Bardy | Dec 2007 | A1 |
20070293740 | Bardy | Dec 2007 | A1 |
20070293741 | Bardy | Dec 2007 | A1 |
20070293772 | Bardy | Dec 2007 | A1 |
20070299325 | Farrell et al. | Dec 2007 | A1 |
20070299617 | Willis | Dec 2007 | A1 |
20080027339 | Nagai et al. | Jan 2008 | A1 |
20080051668 | Bardy | Feb 2008 | A1 |
20080058661 | Bardy | Mar 2008 | A1 |
20080088467 | Al-Ali et al. | Apr 2008 | A1 |
20080091089 | Guillory et al. | Apr 2008 | A1 |
20080091097 | Linti et al. | Apr 2008 | A1 |
20080108890 | Teng et al. | May 2008 | A1 |
20080114232 | Gazit | May 2008 | A1 |
20080139953 | Baker et al. | Jun 2008 | A1 |
20080143080 | Burr | Jun 2008 | A1 |
20080194927 | KenKnight et al. | Aug 2008 | A1 |
20080208009 | Shklarski | Aug 2008 | A1 |
20080208014 | KenKnight et al. | Aug 2008 | A1 |
20080284599 | Zdeblick et al. | Nov 2008 | A1 |
20080288026 | Cross et al. | Nov 2008 | A1 |
20080294024 | Cosentino et al. | Nov 2008 | A1 |
20080177168 | Callahan et al. | Dec 2008 | A1 |
20080306359 | Zdeblick et al. | Dec 2008 | A1 |
20080312522 | Rowlandson et al. | Dec 2008 | A1 |
20090012412 | Wiesel | Jan 2009 | A1 |
20090012979 | Bateni et al. | Jan 2009 | A1 |
20090054737 | Magar | Feb 2009 | A1 |
20090054952 | Glukhovsky et al. | Feb 2009 | A1 |
20090062897 | Axelgaard | Mar 2009 | A1 |
20090069867 | KenKnight et al. | Mar 2009 | A1 |
20090073991 | Landrum et al. | Mar 2009 | A1 |
20090076336 | Mazar et al. | Mar 2009 | A1 |
20090076341 | James et al. | Mar 2009 | A1 |
20090076342 | Amurthur et al. | Mar 2009 | A1 |
20090076343 | James et al. | Mar 2009 | A1 |
20090076346 | James et al. | Mar 2009 | A1 |
20090076349 | Libbus et al. | Mar 2009 | A1 |
20090076397 | Libbus et al. | Mar 2009 | A1 |
20090076401 | Mazar et al. | Mar 2009 | A1 |
20090076559 | Libbus et al. | Mar 2009 | A1 |
20090088652 | Tremblay | Apr 2009 | A1 |
20090112116 | Lee et al. | Apr 2009 | A1 |
20090131759 | Sims et al. | May 2009 | A1 |
20090156908 | Belalcazar et al. | Jun 2009 | A1 |
20090216132 | Orbach | Aug 2009 | A1 |
20090270708 | Shen et al. | Oct 2009 | A1 |
20090270747 | Van Dam et al. | Oct 2009 | A1 |
20090292194 | Libbus et al. | Nov 2009 | A1 |
20100007413 | Herleikson et al. | Jan 2010 | A1 |
20100022897 | Parker et al. | Jan 2010 | A1 |
20100056881 | Libbus et al. | Mar 2010 | A1 |
20100081913 | Cross et al. | Apr 2010 | A1 |
20100174229 | Hsu et al. | Jul 2010 | A1 |
20100177100 | Carnes et al. | Jul 2010 | A1 |
20100185063 | Bardy | Jul 2010 | A1 |
20100185076 | Jeong et al. | Jul 2010 | A1 |
20100191154 | Berger et al. | Jul 2010 | A1 |
20100191310 | Bly | Jul 2010 | A1 |
20100223020 | Goetz | Sep 2010 | A1 |
20100234715 | Shin | Sep 2010 | A1 |
20100234716 | Engel | Sep 2010 | A1 |
20100280366 | Arne et al. | Nov 2010 | A1 |
20100312188 | Robertson et al. | Dec 2010 | A1 |
20100324384 | Moon et al. | Dec 2010 | A1 |
20110021937 | Hugh et al. | Jan 2011 | A1 |
20110054286 | Crosby et al. | Mar 2011 | A1 |
20110060215 | Tupin et al. | Mar 2011 | A1 |
20110066041 | Pandia et al. | Mar 2011 | A1 |
20110077497 | Oster et al. | Mar 2011 | A1 |
20110105861 | Derchak | May 2011 | A1 |
20110144470 | Mazar et al. | Jun 2011 | A1 |
20110160548 | Forster | Jun 2011 | A1 |
20110224564 | Moon et al. | Sep 2011 | A1 |
20110237922 | Parker, III et al. | Sep 2011 | A1 |
20110237924 | McGusty et al. | Sep 2011 | A1 |
20110245699 | Snell et al. | Oct 2011 | A1 |
20110245711 | Katra et al. | Oct 2011 | A1 |
20110288605 | Kalb et al. | Nov 2011 | A1 |
20120003933 | Baker et al. | Jan 2012 | A1 |
20120029306 | Paquet et al. | Feb 2012 | A1 |
20120029315 | Raptis et al. | Feb 2012 | A1 |
20120029316 | Raptis et al. | Feb 2012 | A1 |
20120035432 | Katra et al. | Feb 2012 | A1 |
20120059668 | Baldock et al. | Mar 2012 | A1 |
20120078127 | McDonald et al. | Mar 2012 | A1 |
20120088998 | Bardy et al. | Apr 2012 | A1 |
20120088999 | Bishay et al. | Apr 2012 | A1 |
20120089000 | Bishay et al. | Apr 2012 | A1 |
20120089001 | Bishay et al. | Apr 2012 | A1 |
20120089037 | Bishay et al. | Apr 2012 | A1 |
20120089412 | Bardy et al. | Apr 2012 | A1 |
20120089417 | Bardy et al. | Apr 2012 | A1 |
20120095352 | Tran | Apr 2012 | A1 |
20120101358 | Boettcher et al. | Apr 2012 | A1 |
20120101396 | Solosko et al. | Apr 2012 | A1 |
20120165645 | Russel et al. | Jun 2012 | A1 |
20120306662 | Vosch et al. | Jun 2012 | A1 |
20120172695 | Ko et al. | Jul 2012 | A1 |
20120220835 | Chung | Aug 2012 | A1 |
20120232929 | Experton | Sep 2012 | A1 |
20120238910 | Nordstrom | Sep 2012 | A1 |
20120246795 | Scheffler | Oct 2012 | A1 |
20120253847 | Dell'Anno et al. | Oct 2012 | A1 |
20120302906 | Felix et al. | Nov 2012 | A1 |
20120330126 | Hoppe et al. | Dec 2012 | A1 |
20130041272 | Javier et al. | Feb 2013 | A1 |
20130077263 | Oleson et al. | Mar 2013 | A1 |
20130079611 | Besko | Mar 2013 | A1 |
20130085347 | Manicka et al. | Apr 2013 | A1 |
20130085403 | Gunderson et al. | Apr 2013 | A1 |
20130087609 | Nichol et al. | Apr 2013 | A1 |
20130096395 | Katra et al. | Apr 2013 | A1 |
20130116533 | Lian et al. | May 2013 | A1 |
20130123651 | Bardy | May 2013 | A1 |
20130158361 | Bardy | Jun 2013 | A1 |
20130197380 | Oral et al. | Aug 2013 | A1 |
20130225963 | Kodandaramaiah et al. | Aug 2013 | A1 |
20130225966 | Macia Barber et al. | Aug 2013 | A1 |
20130231947 | Shusterman | Sep 2013 | A1 |
20130243105 | Lei et al. | Sep 2013 | A1 |
20130274584 | Finlay et al. | Oct 2013 | A1 |
20130275158 | Fahey | Oct 2013 | A1 |
20130324809 | Lisogurski et al. | Dec 2013 | A1 |
20130324855 | Lisogurski et al. | Dec 2013 | A1 |
20130324856 | Lisogurski et al. | Dec 2013 | A1 |
20130325081 | Karst et al. | Dec 2013 | A1 |
20130325359 | Jarverud et al. | Dec 2013 | A1 |
20130331665 | Libbus et al. | Dec 2013 | A1 |
20130338448 | Libbus et al. | Dec 2013 | A1 |
20130338472 | Macia Barber et al. | Dec 2013 | A1 |
20140012154 | Mazar et al. | Jan 2014 | A1 |
20140056452 | Moss et al. | Feb 2014 | A1 |
20140088399 | Lian et al. | Mar 2014 | A1 |
20140107509 | Banet et al. | Apr 2014 | A1 |
20140140359 | Kalevo et al. | May 2014 | A1 |
20140180027 | Buller | Jun 2014 | A1 |
20140189928 | Oleson et al. | Jul 2014 | A1 |
20140206977 | Bahney et al. | Jul 2014 | A1 |
20140214134 | Peterson | Jul 2014 | A1 |
20140215246 | Lee et al. | Jul 2014 | A1 |
20140249852 | Proud | Sep 2014 | A1 |
20140296651 | Stone | Oct 2014 | A1 |
20140343390 | Berzowska et al. | Nov 2014 | A1 |
20140358193 | Lyons et al. | Dec 2014 | A1 |
20140364756 | Brockway et al. | Dec 2014 | A1 |
20150048836 | Guthrie et al. | Feb 2015 | A1 |
20150065842 | Lee et al. | Mar 2015 | A1 |
20150164349 | Gopalakrishnan et al. | Jun 2015 | A1 |
20150165211 | Naqvi et al. | Jun 2015 | A1 |
20150177175 | Elder et al. | Jun 2015 | A1 |
20150250422 | Bay | Sep 2015 | A1 |
20150257670 | Ortega et al. | Sep 2015 | A1 |
20150305676 | Shoshani | Nov 2015 | A1 |
20150359489 | Baudenbacher et al. | Dec 2015 | A1 |
20160135746 | Kumar et al. | May 2016 | A1 |
20160144190 | Cao et al. | May 2016 | A1 |
20160144192 | Sanghera et al. | May 2016 | A1 |
20160150982 | Roy | Jun 2016 | A1 |
20160217691 | Kadobayashi et al. | Jul 2016 | A1 |
20160235318 | Sarkar | Aug 2016 | A1 |
20190021671 | Kumar et al. | Jan 2019 | A1 |
Number | Date | Country |
---|---|---|
19955211 | May 2001 | DE |
1859833 | Nov 2007 | EP |
2438851 | Apr 2012 | EP |
2438852 | Apr 2012 | EP |
2465415 | Jun 2012 | EP |
2589333 | May 2013 | EP |
H06319711 | Nov 1994 | JP |
H11188015 | Jul 1999 | JP |
2004129788 | Apr 2004 | JP |
2007082938 | Apr 2007 | JP |
2009219554 | Oct 2009 | JP |
199852463 | Nov 1998 | WO |
0078213 | Dec 2000 | WO |
2003032192 | Apr 2003 | WO |
2006009767 | Jan 2006 | WO |
2006014806 | Feb 2006 | WO |
2007066270 | Jun 2007 | WO |
2007092543 | Aug 2007 | WO |
2008010216 | Jan 2008 | WO |
2008057884 | May 2008 | WO |
2008092098 | Jul 2008 | WO |
2009036306 | Mar 2009 | WO |
2009036313 | Mar 2009 | WO |
2009036327 | Mar 2009 | WO |
2009112976 | Sep 2009 | WO |
2009112978 | Sep 2009 | WO |
2009112979 | Sep 2009 | WO |
2009142975 | Nov 2009 | WO |
2010066507 | Jun 2010 | WO |
2010105045 | Sep 2010 | WO |
2011047207 | Apr 2011 | WO |
2012140559 | Oct 2012 | WO |
2012146957 | Nov 2012 | WO |
Entry |
---|
15 of the Hottest Wearable Gadgets, URL <http://thehottestgadgets.com/2008/09/the-15-hottest-wearable-gadgets-001253> (Web page cached on Sep. 27, 2008). |
Alivecor, URL <http://www.businesswire.com/news/home/20121203005545/en/AliveCor%E2%80%99s-Heart-Monitor-Phone-Receives-FDA-Clearance#.U7rtq7FVTyF> (Dec. 3, 2012). |
Bharadwaj et al., Techniques for Accurate ECG signal processing, EE Times, URL <www.eetimes.com/document.asp?doc_id=1278571> (Feb. 14, 2011). |
Chen et al. “Monitoring Body Temperature of Newborn Infants At Neonatal Intensive Care Units Using Wearable Sensors,” BodyNets 2010, Corfu Island, Greece. Sep. 10-12, 1210. |
Epstein, Andrew E. et al.; ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. J. Am. Coll. Cardiol. 2008; 51; el-e62, 66 Pgs. |
Fitbit Tracker, URL <http://www.fitbit.com/> (Web page cached on Sep. 10, 2008.). |
Smith, Jawbone Up, URL <http://www.businessinsider.com/fitbit-flex-vs-jawbone-up-2013-5?op=1> (Jun. 1, 2013). |
Kligfield, Paul et al., Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part I. J.Am.Coll. Cardiol; 2007; 49; 1109-27, 75 Pgs. |
Lauren Gravitz, “When Your Diet Needs A Band-Aid,”Technology Review, MIT. (May 1, 2009). |
Lieberman, Jonathan, “How Telemedicine Is Aiding Prompt ECG Diagnosis In Primary Care,” British Journal of Community Nursing, vol. 13, No. 3, Mar. 1, 2008 (Mar. 1, 2008), pp. 123-126, XP009155082, ISSN: 1462-4753. |
McManus et al., “A Novel Application for the Detection of an Irregular Pulse using an iPhone 4S in Patients with Atrial Fibrillation,” vol. 10(3), pp. 315-319 (Mar. 2013.). |
Nike+ Fuel Band, URL <http://www.nike.com/us/en_us/c/nikeplus-fuelband> (Web page cached on Jan. 11, 2013.). |
P. Libby et al.,“Braunwald's Heart Disease—A Textbook of Cardiovascular Medicine,” Chs. 11, pp. 125-148 and 12, pp. 149-193 (8th ed. 2008), American Heart Association. |
Initial hands-on with Polar Loop activity tracker, URL <http://www.dcrainmaker.com/2013/09/polar-loop-firstlook.html> (Sep. 17, 2013). |
Seifert, Dan, Samsung dives into fitness wearable with the Gear Fit/ The Verge, URL <http://www.theverge.com/2014/2/24/5440310/samsung-dives-into-fitness-wearables-with-the-gear-fit> (Feb. 24, 2014). |
Soper, Taylor, Samsung's new Galaxy S5 flagship phone has fingerprint reader, heart rate monitor, URL <http://www.geekwire.com/2014/samsung-galaxy-s5-fingerprint> (Feb. 24, 2014). |
Dolcourt, See the Samsung Galaxy S5's Heart rate monitor in action, URL <http://www.cnet.com/news/see-the-samsung-galaxy-s5s-heart-rate-monitor-in-action> (Feb. 25, 2014). |
Sittig et al., “A Computer-Based Outpatient Clinical Referral System,” International Journal of Medical Informatics, Shannon, IR, vol. 55, No. 2, Aug. 1, 1999, pp. 149-158, XO004262434, ISSN: 1386-5056(99)00027-1. |
Sleepview, URL <http://www.clevemed.com/sleepview/overview.shtml> (Web page cached on Sep. 4, 2013.). |
Actigraphy/ Circadian Rhythm SOMNOwatch, URL <http://www.somnomedics.eu/news-events/publications/somnowatchtm.html> (Web page cached on Jan. 23, 2010). |
Zio Event Card, URL <http://www.irhythmtech.com/zio-solution/zio-event/> (Web page cached on Mar. 11, 2013.). |
Zio Patch System, URL <http://www.irhythmtech.com/zio-solution/zio-system/index.html> (Web page cached on Sep. 8, 2013.). |
Saadi et al. “Heart Rhythm Analysis Using ECG Recorded With A Novel Sternum Based Patch Technology—A Pilot Study.” Cardio technix 2013—Proceedings of the International Congress on Cardiovascular Technologies, Sep. 20, 2013. |
Anonymous. “Omegawave Launches Consumer App 2.0 in U.S. Endurance Sportswire—Endurance Sportswire.” Jul. 11, 2013. URL:http://endurancesportswire.com/omegawave-launches-consumer-app-2-0-in-u-s/. |
Chan et al. “Wireless Patch Sensor for Remote Monitoring of Heart Rate, Respiration, Activity, and Falls.” pp. 6115-6118. 2013 35th Annual International Conference of the IEEE Engineering in Medical and Biology Society. Jul. 1, 2013. |
Wei et al. “A Stretchable and Flexible System for Skin-Mounted Measurement of Motion Tracking and Physiological Signals.” pp. 5772-5775. 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. Aug. 26, 2014. |
Daoud et al. “Fall Detection Using Shimmer Technology and Multiresolution Analysis.” Aug. 2, 2013. URL: https://decibel.ni.com/content/docs/DOC-26652. |
Libbus. “Adherent Cardiac Monitor With Wireless Fall Detection For Patients With Unexplained Syncope.” Abstracts of the First AMA-IEEE Medical Technology Conference On Individualized Healthcare. May 22, 2010. |
Duttweiler et al., “Probability Estimation In Arithmetic And Adaptive-Huffman Entropy Coders,” IEEE Transactions on Image Processing. vol. 4, No. 3, Mar. 1, 1995, pp. 237-246. |
Gupta et al., “An ECG Compression Technique For Telecardiology Application,” India Conference (INDICON), 2011 Annual IEEE, Dec. 16, 2011, pp. 1-4. |
Nave et al., “ECG Compression Using Long-Term Prediction,” IEEE Transactions on Biomedical Engineering, IEEE Service Center, NY, USA, vol. 40, No. 9, Sep. 1, 1993, pp. 877-885. |
Skretting et al., “Improved Huffman Coding Using Recursive Splitting,” NORSIG, Jan. 1, 1999. |
A Voss et al., “Linear and Nonlinear Methods for Analyses of Cardiovascular Variability in Bipolar Disorders,” Bipolar Disorders, votl. 8, No. 5p1, Oct. 1, 2006, pp. 441-452, XP55273826, DK ISSN: 1398-5647, DOI: 10.1111/.1399-5618.2006.00364.x. |
Varicrad-Kardi Software User's Manual Rev. 1.1, Jul. 8, 2009 (Jul. 8, 2009), XP002757888, retrieved from the Internet: URL:http://www.ehrlich.tv/KARDiVAR-Software.pdf [retrieved on May 20, 2016]. |
Vedapulse UK, Jan. 1, 2014 (Jan. 1, 2014), XP002757887, Retrieved from the Internet: URL:http://www.vedapulseuk.com/diagnostic/ [retrieved on May 19, 2016]. |
http://www.originlab.com/origin#Data_Exploration 2015. |
https://web.archive.org/web/20130831204020/http://www.biopac.com/research.asp?CatID=37&Main=Software (Aug. 2013). |
Adinstruments:ECG Analysis Module for LabChart & PowerLab, 2008. |
Biopac Systems, Inc. #AS148—Automated ECG Analysis , Mar. 24, 2006. |
Health Research—Hexoskin Biometric Shirt | Hexoskin URL:http://www.hexoskin.com/pages/health-research (Web page cached on Dec. 2, 2014). |
Jacob Kastrenakes, “Apple Watch uses four sensors to detect your pulse,” Sep. 9, 2014. URL: http://www.theverge.com/2014/9/9/6126991/apple-watch-four-back-sensors-detect-activity. |
Nicole Lee, “Samsung Gear S review: an ambitious and painfully flawed smartwatch,” Dec. 1, 2014. URL: http://www.engadget.com/2014/12/01/samsung-gear-s-review/. |
G. G. Ivanov, “HRV Analysis Under The Usage Of Different Electrocardiopraphy Systems,” Apr. 15, 2008 (Apr. 15, 2008), XP55511209, Retrieved from the Internet: URL:http://www.drkucera.eu/upload_doc/hrv_analysis_(methodical_recommendations).pdf [retrieved on Oct. 1, 2018]. |
http://www.gtec.at/Products/Software/g.BSanalyze-Specs-Features (2014). |
Number | Date | Country | |
---|---|---|---|
20190231213 A1 | Aug 2019 | US |
Number | Date | Country | |
---|---|---|---|
61882403 | Sep 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15602003 | May 2017 | US |
Child | 16378458 | US | |
Parent | 14734853 | Jun 2015 | US |
Child | 15602003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14463585 | Aug 2014 | US |
Child | 14734853 | US | |
Parent | 14080717 | Nov 2013 | US |
Child | 14463585 | US |